04/10/2025
4:27 PM | Skye Bioscience (Subject)
Skye Bioscience (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
| Form SCHEDULE 13G/A | |
03/20/2025
3:03 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/20/2025
3:04 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2025
5:54 PM | ARSENAULT KAITLYN (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4/A | |
02/26/2025
6:45 PM | Schwab Andrew J. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
4:53 PM | ARSENAULT KAITLYN (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
4:27 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2025
4:34 PM | Arora Puneet S. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
4:38 PM | Diep Tuan Tu (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
4:41 PM | Charych Deborah H. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
4:43 PM | DHILLON PUNIT (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for SKYE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Skye Bioscience and its competitors with MarketBeat's FREE daily newsletter. |
02/26/2025
4:45 PM | Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Smith Karen L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
4:47 PM | Grayson Paul A. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
4:51 PM | Jenkins Annalisa (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
5:09 PM | 5AM Partners VII, LLC (Filed by)
Skye Bioscience (Subject)
Skye Bioscience (Subject)
| Form SCHEDULE 13D/A | |
11/20/2024
7:23 AM | Diep Tuan Tu (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
8:57 PM | ARSENAULT KAITLYN (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
8:14 PM | Grayson Paul A. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
8:20 PM | DHILLON PUNIT (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
4:22 PM | Grayson Paul A. (Reporting)
Skye Bioscience (Subject)
Skye Bioscience (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2024
4:25 PM | Diep Tuan Tu (Reporting)
Skye Bioscience (Subject)
Skye Bioscience (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2024
4:28 PM | DHILLON PUNIT (Reporting)
Skye Bioscience (Subject)
Skye Bioscience (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2024
4:31 PM | ARSENAULT KAITLYN (Reporting)
Skye Bioscience (Subject)
Skye Bioscience (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
9:02 AM | JANUS HENDERSON GROUP PLC (Filed by)
Skye Bioscience (Subject)
Skye Bioscience (Subject)
| Form SC 13G/A | |
11/14/2024
8:21 AM | Altium Capital Management LP (Filed by)
Skye Bioscience (Subject)
Skye Bioscience (Subject)
| Form SC 13G/A | |
10/30/2024
7:25 PM | Jenkins Annalisa (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
7:25 PM | Charych Deborah H. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
7:28 PM | Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Smith Karen L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
7:29 PM | Grayson Paul A. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
7:30 PM | Schwab Andrew J. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
7:31 PM | DHILLON PUNIT (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
7:32 PM | ARSENAULT KAITLYN (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
7:33 PM | Diep Tuan Tu (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
4:25 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
3:59 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
4:25 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form DEF 14A | |
09/13/2024
5:54 PM | 5AM CO-INVESTORS II LP (Reporting)
5AM Partners II, LLC (Reporting)
5AM Partners VII, LLC (Reporting)
5AM Ventures II LP (Reporting)
5AM Ventures VII, L.P. (Reporting)
DIEKMAN JOHN D (Reporting)
PARMAR KUSH (Reporting)
ROCKLAGE SCOTT M (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
5:56 PM | Schwab Andrew J. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:18 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form PRE 14A | |
09/04/2024
5:12 PM | Arora Puneet S. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
4:25 PM | Arora Puneet S. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad) Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade.
In 2023, it surged 239%. And in 2024, it soared another 171% on the year…
But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less? Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. |
08/27/2024
4:20 PM | DHILLON PUNIT (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
4:18 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2024
4:29 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/05/2024
7:58 AM | Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Smith Karen L. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/05/2024
7:59 AM | Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Smith Karen L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
6:05 AM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2024
8:27 AM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy SKYE Stock Free SKYE Stock Alerts